Article
Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.
Clinical pharmacology and therapeutics - 1 Aug 1994
Agúndez J A, Martínez C, Olivera M, Ledesma M C, Ladero J M, Benítez J
Abstract excerpt
The arylamine N-acetyltransferase (NAT-2) polymorphism causes impaired drug metabolism in about half of the white population. By the combined use of polymerase chain reaction (PCR) and restriction mapping with the endonucleases Fok I and Dde I, we have studied the genetic basis underlying NAT-2 polymorphism in genomic deoxyribonucleic acid from 245 healthy Spaniards. The study of three mutations at the NAT-2 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
